Management tracks: United Neuroscience, Zymergen

Neurodegenerative diseases company United Neuroscience Ltd. (Dublin, Ireland) hired Peter Powchik as its first EVP of R&D, effective Jan. 1. He was SVP of clinical development at Regeneron Pharmaceuticals Inc. (NASDAQ:REGN).

Zymergen Inc. (Emeryville, Calif.) hired Jens Peter Clausen as SVP of global manufacturing, a newly created position. The company, which uses artificial intelligence to search the microbial genome for new materials that could replace petroleum-based products in the agriculture, chemical and pharmaceutical sectors, raised over $400 million this month in a series C round...